TBFA
EW icon

Three Bearings Fiduciary Advisors’s Edwards Lifesciences EW Stock Holding History

Three Bearings Fiduciary Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10
Closed -$814 – 356
2025
Q4 		$814 Buy
+10
New +$821 ﹤0.01% 321

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Three Bearings Fiduciary Advisors's EW Position: Q1 2026 in Review

Three Bearings Fiduciary Advisors sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 10 shares — an estimated $814 sold.

Three Bearings Fiduciary Advisors first reported a position in EW in Q4 2025 and held it in 1 quarter. The position peaked at $814 in Q4 2025. 1,287 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Three Bearings Fiduciary Advisors reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
  • Three Bearings Fiduciary Advisors sold 10 Edwards Lifesciences shares in Q1 2026, an estimated $814.
  • Three Bearings Fiduciary Advisors first reported a position in Edwards Lifesciences in Q4 2025 and held it in 1 quarter.
  • Three Bearings Fiduciary Advisors's Edwards Lifesciences position peaked at $814 in Q4 2025.
  • 1,287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Three Bearings Fiduciary Advisors's 13F filing for Q1 2026, filed 11 Jun 2026.